NCT07566585
- Conditions
- AML - Acute Myeloid Leukemia, AML With Mutated NPM1, AML, Adult Recurrent, +11 more
- Locations
-
- Washington University at St Louis St Louis, Missouri, United States
Clinical trial condition
AML - Acute Myeloid Leukemia
Explore clinical trials studying AML - Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.
7 public trials
4 recruiting studies
AML - Acute Myeloid Leukemia trial results
NCT06994676
- Conditions
- AML - Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- City of Hope Duarte, California, United States
- Stanford Medical Center Palo Alto, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern Medicine Chicago, Illinois, United States
NCT06782971
- Conditions
- AML - Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Canberra Health Services Canberra, Australian Capital Territory, Australia
- Prince of Wales Hospital Sydney, New South Wales, Australia
- Royal North Shore Hospital Sydney, New South Wales, Australia
- Westmead Hospital Westmead, New South Wales, Australia
NCT06696183
- Conditions
- AML - Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Technische Universität Dresden Dresden, Germany
Enrolling by Invitation
A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML): DLIT-AML
NCT07014462
- Conditions
- AML - Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- University of Vermont Medical Center Burlington, Vermont, United States
Not Yet Recruiting
CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia
NCT07201727
- Conditions
- AML - Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
Not specified
Not Yet Recruiting
Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation
NCT07025824
- Conditions
- AML - Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +11 more
- Locations
-
- Medizinische Fakultät der TU Dresden, Medizinische Klinik und Poliklinik I Dresden, Germany
- Universitätsmedizin Halle (Saale) Halle, Germany
- Universitätsklinikum Schleswig-Holstein, Campus Kiel Kiel, Germany
- Universitätsklinikum Münster, Medizinische Klinik A, KMT-Zentrum Münster, Germany